x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The Scalpel"s Edge

The Scalpel"s Edge is a podcast hosted by Dr. Tim Sayed, a leading plastic surgeon and physician innovator, dedicated to exploring the forefront of excellence and wellness. The show delves into cutting-edge medical technologies, industry controversies, and innovative approaches to healthcare and personal growth. With insightful discussions featuring top leaders and innovators from healthcare and beyond, the podcast aims to optimize performance, enhance wellness, and deepen self-understanding

health & fitness medicine

All Episodes

27:50

Ep. 30 - Oral GLP 1 Is Here - What It Means for...

The Scalpel"s Edge ·

2026/04/07

Dr. Tim Sayed takes a closer look at the latest shift in medically supervised weight loss with the FDA approval of an oral GLP-1 medication. After years of injections dominating the space, a once daily pill introduces a new layer of accessibility, convenience, and patient choice. He walks through how these medications actually work in the body, from slowing gastric emptying to quieting food noise, and why they’ve been so impactful for patients struggling with weight loss. The conversation sta...

en

19:35

Ep. 29 - What a New Oral GLP-1 Study Means for Type 2...

The Scalpel"s Edge ·

2026/03/03

Dr. Tim Sayed takes a thoughtful look at newly published data from the Achieve 3 trial, a 52-week head-to-head study comparing Eli Lilly’s investigational oral GLP-1, orforglipron, to oral semaglutide in adults with type 2 diabetes not adequately controlled on metformin. Published in The Lancet, the study showed greater A1C reduction and more weight loss at higher doses of orforglipron, with improvements appearing as early as four weeks and sustained through the full year. Participants also s...

en

29:37

Ep. 28 - GLP-1 Weight Loss Is Changing Fast. Here’s...

The Scalpel"s Edge ·

2026/02/17

On The Scalpel’s Edge, Dr. Tim Sayed takes a clear-eyed look at where GLP-1 weight loss medications are headed and why the landscape feels so unsettled right now. From the FDA’s latest move against compounded GLP-1 drugs to the rise of direct-to-consumer platforms and the new TrumpRX pricing model, this is an honest, surgeon-level reflection on access, affordability, and control. Dr. Sayed shares how these shifts affect real patients, real practices, and the expectations around weight loss, p...

en

24:40

Ep. 27 - What Really Happens When You Stop GLP-1’s...

The Scalpel"s Edge ·

2026/02/03

Dr. Tim Sayed walks through some recent developments in the GLP-1 space that raise a question almost everyone on these medications eventually asks. What happens when you stop. He reflects on new data around weight regain after discontinuing GLP-1 drugs, including a large meta-analysis showing how quickly weight and metabolic markers tend to return toward baseline once the medication is stopped. He also breaks down early clinical data on an endoscopic procedure called Revita that aims to suppo...

en

59:10

Ep. 26 - Breast Implant Illness and the Moment...

The Scalpel"s Edge ·

2026/01/13

On The Scalpel’s Edge, Dr. Tim Sayed talks with Elizabeth Everett about her experience with breast implant illness and what it was like to spend years feeling dismissed while her body kept sending louder and louder signals. She shares why she chose implants after having her third son, how symptoms slowly built over time, and the way stress, hormones, and a foreign body in her system seemed to create a perfect storm. Elizabeth walks through the health changes that pushed her to keep searching ...

en

23:06

Ep. 25 - Understanding GLP1 Side Effects with Dr. Tim...

The Scalpel"s Edge ·

2025/12/30

In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the latest research on GLP1 medications and the lesser known side effects patients may experience. Drawing from new studies, clinical insights, and his own experience with GLP1 therapy, Dr. Sayed breaks down how these medications may influence anemia risk, micronutrient deficiencies, appetite changes, and overall metabolic health. He also explores new data on hemoglobin changes, iron intake, B12 levels, and nutritiona...

en

37:09

Ep. 24 - How Genetic Testing Supports Explant Surgery...

The Scalpel"s Edge ·

2025/12/16

In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes listeners inside the world of personalized genetic testing and how it can transform perioperative planning for explant patients and anyone seeking deeper insight into their inflammatory health. Dr. Sayed breaks down the SHARP program’s integrated approach, which combines genomic testing, supplements, psychological support, and lifestyle guidance to help patients understand their unique risks, strengths, and metabolic tendencies. Using...

en

29:28

Ep. 23 - Why Twenty Four Celebrities Chose Breast...

The Scalpel"s Edge ·

2025/12/02

Explore the growing movement of breast implant removal as Dr. Tim Sayed breaks down why twenty four well known celebrities decided to explant. In this powerful episode of The Scalpel’s Edge, Dr. Sayed explains the emotional, physical, and aesthetic reasons behind their decisions and highlights the rising awareness around breast implant illness, autoimmune symptoms, and personal identity. He also shares insights from his double board certified surgical practice, where he focuses on explant sur...

en

30:23

Ep. 22 - Oral GLP-1 Breakthroughs and the Future of...

The Scalpel"s Edge ·

2025/11/18

A new era of weight management is on the horizon. In this episode of The Scalpel’s Edge, learn how oral GLP-1 medications like semaglutide (Rebelsus) are changing the landscape of obesity care and cardiovascular health. Explore key findings from the OASIS-4 Phase 3 trial, new FDA updates, and what the data reveals about blood sugar control, heart health, and weight reduction across all age groups. Discover why oral options may soon rival injectables like Ozempic, Wegovy, and Mounjaro—and what...

en

39:34

Ep. 21 - Clinical Outcomes After Explant Surgery for...

The Scalpel"s Edge ·

2025/11/04

In this episode of The Scalpel’s Edge, Dr. Tim Sayed reviews a newly published study from Colombia examining outcomes in women with breast implant illness following explant surgery. With over 125 patients and 18 months of follow-up, this research reveals significant improvements in symptoms such as joint pain, fatigue, and hair loss — and offers valuable insight into the science, skepticism, and evolving understanding of BII. Dr. Sayed breaks down the data, discusses parallels with U.S. studi...

en

34:17

Ep. 20 - The Rise of Explant Surgery and the Power of...

The Scalpel"s Edge ·

2025/10/21

In this episode of The Scalpel’s Edge, Dr. Tim Sayed breaks down a recent CNN feature on the growing movement around explant surgery and breast implant illness. From celebrity testimonials like Alyssa Milano’s to the troubling stories of patients who felt pressured by surgeons, Dr. Sayed dives deep into what’s driving the rise in breast implant removals. He explores the science, the stigma, and the shifting mindset around body image, empowerment, and patient choice. Together, we examine how t...

en

28:58

Ep. 19 - FDA Warnings, Compounded GLP1s, and the Next...

The Scalpel"s Edge ·

2025/10/07

In this episode of The Scalpel’s Edge, Dr. Tim Sayed takes a deep dive into the shifting regulatory landscape for compounded GLP1 medications and what recent FDA warning letters mean for providers, pharmacies, and patients. He also reviews promising new clinical trial data on Pfizer’s experimental drug MET97, which may offer greater weight loss with fewer side effects compared to current options. From the nuances of verbiage in compounding claims to the future of monthly dosing and oral formu...

en

25:51

Ep. 18 - GLP1 Medications Heart Health and...

The Scalpel"s Edge ·

2025/09/09

On this episode of The Scalpel’s Edge we explore a fascinating new study showing how GLP1 medications like semaglutide and tirzepatide may not only improve heart failure outcomes but also reduce greenhouse gas emissions. As I break down this meta-analysis presented at the European Society of Cardiology Congress you will hear how these drugs can deliver benefits for individual patients while also contributing to global sustainability efforts. Small improvements at the patient level may add up ...

en

37:05

Ep. 17 - Breast Implant Illness: What the Data Reveals

The Scalpel"s Edge ·

2025/08/26

In this episode of The Scalpel’s Edge, Dr. Tim Sayed examines one of the most debated topics in plastic surgery, breast implant illness. He reviews findings from a arecent cohort study published in Cureus while also drawing from his experience as a double board certified plastic surgeon. The discussion explores patient outcomes after explant surgery, the role of inflammation, and the balance between correlation and causation. Dr. Sayed provides historical context, addresses ongoing controvers...

en

24:46

Ep. 16 - Reset the Clock Not the Hormones

The Scalpel"s Edge ·

2025/08/12

On this episode of The Scalpel’s Edge, I’m diving into a fascinating new study that compares GLP-1 drugs like tirzepatide to traditional testosterone replacement therapy in men with obesity and low testosterone function. The results? Pretty eye-opening. We’ll break down how these medications - originally developed for weight loss and diabetes - are now showing promise in naturally improving testosterone levels by reactivating your body’s own hormone pathways, rather than just patching things ...

en

28:23

Ep. 15 - GLP1 Breakthroughs and Real Results

The Scalpel"s Edge ·

2025/07/29

In this episode of The Scalpel’s Edge, Dr. Tim Sayed breaks down compelling new research on GLP1 medications like semaglutide, tirzepatide, and the latest entrant, ecnoglutide. With real-world data from Cleveland Clinic and insights from an international Phase 3 trial, Dr. Sayed explores how these medications are performing outside of clinical trials, what happens after patients stop taking them, and why cost, side effects, and genetic profiles may impact their effectiveness. As a board...

en

27:13

Ep. 14 - Inside the SHARP Program: A Doctor’s Journey...

The Scalpel"s Edge ·

2025/07/15

In this episode of The Scalpel’s Edge, Dr. Tim Sayed shares an inside look at a new chapter in his practice. The SHARP Program, also known as the Strategic Holistic Accelerated Recovery Program, was developed by Dr. Robert Whitfield to support explant patients through personalized wellness and recovery. Dr. Sayed walks through the details of his own participation in the program, breaking down the lab kits, testing protocols, and insights they provide. He covers everything from urine metabolit...

en

25:47

Ep. 13 - Feeling Exhausted, Achy, And Foggy? This...

The Scalpel"s Edge ·

2025/07/01

In this solo episode, Dr. Tim Sayed takes listeners behind the scalpel to explore a topic that’s both controversial and critical: breast implant illness (BII). With honesty and compassion, he unpacks the common symptoms that may indicate a deeper issue—from chronic fatigue and joint pain to unexplained anxiety—and how continuous exposure to implants may trigger systemic inflammation in the body. He also shares practical, evidence-informed advice on how to vet surgeons, where to find support g...

en

26:41

Ep. 12 - Is Breast Implant Illness Real? New Study...

The Scalpel"s Edge ·

2025/06/17

What if science could validate what thousands of women have already reported? In this episode of The Scalpel’s Edge, Dr. Tim Sayed unpacks a newly published study in Nature Portfolio that may mark a turning point in how we understand breast implant illness (BII). The study reveals a statistically significant spike in FGF-19—a critical metabolic and healing biomarker—after explant surgery, reinforcing what many in the BII community have experienced firsthand. But is this just a side effect of ...

en

35:05

Ep. 11 - Fasting, Fat Burn, And Faith: What Ramadan...

The Scalpel"s Edge ·

2025/06/03

In this powerful episode of The Scalpel’s Edge, Dr. Tim Sayed, a double board-certified plastic surgeon and holistic wellness expert, dives deep into the intersection of science, spirituality, and self-discipline. Using his own experience with Ramadan fasting as a lens, Dr. Sayed unpacks the compelling health benefits of intermittent fasting — from fat loss and improved metabolic markers to enhanced emotional well-being and even athletic performance. But this isn't just another episode on die...

en

31 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown